Dividend Stock Portfolio: 5 Stock Picks By Hedge Funds

4. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 73

Dividend Yield: 3.3%

Bristol-Myers Squibb Company (NYSE:BMY) is a healthcare company based in New York and ranks 4th on our list of stock picks by hedge funds. The company offers healthcare products in hematology, oncology, cardiovascular, and immunology therapeutic classes.

As of this July Truist holds a Buy rating and a $74 price target on shares of Bristol-Myers Squibb Company (NYSE:BMY).

In the second quarter of 2021, Bristol-Myers Squibb Company (NYSE:BMY) had an EPS of $1.93, beating estimates by $0.03. The company’s revenue was $11.70 billion, up 15.54% year over year and beating estimates by $474.30 million. Bristol-Myers Squibb Company (NYSE:BMY) has gained 0.52% in the past year.

By the end of the second quarter of 2021, 73 hedge funds out of the 873 tracked by Insider Monkey held stakes in Bristol-Myers Squibb Company (NYSE:BMY) worth roughly $5.2 billion. This is compared to 81 hedge funds in the previous quarter with a total stake value of approximately $5 billion.